Encompass Health Corp
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $5.9B | $5.4B | $4.8B | $4.3B | $4.0B |
| Operating income | — | — | — | $539.5M | $559.6M |
| Cash from operations | $1.2B | $1.0B | $850.8M | $705.8M | $715.8M |
| Capital expenditure | $736.4M | $642.5M | $583.1M | $564.8M | $524.6M |
| Free cash flow | $439.2M | $360.3M | $267.7M | $141.0M | $191.2M |
| Share repurchases | $158.0M | $31.1M | $0 | $0 | $0 |
| Total assets | $7.1B | $6.5B | $6.1B | $5.6B | $6.9B |
| Total liabilities | $3.8B | $3.7B | $3.8B | $3.8B | $4.5B |
| Total debt | $2.5B | $2.5B | $2.7B | $2.8B | $3.3B |
Shares outstanding 99.2M · Free float 85.9%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.
Recent filings
- June 1, 2026 8-K
- May 15, 2026 8-K
- May 11, 2026 8-K
- May 1, 2026 10-Q
- April 30, 2026 8-K
- March 10, 2026 8-K
- February 26, 2026 10-K
- February 20, 2026 8-K/A